glutathione pubchem disulfide dianion | C20H30N6O12S2-2 | CID 40467895 Glutathione - an overview |

9 , e1003750 (2013)

Published on November 23rd, 2025

Reversible skin hyperpigmentation in imerslund-grasbeck syndrome

Why this trial matters : First ADC to move into the 1L HER2+ metastatic setting Breaks a decade-long treatment paradigm in first-line breast cancer care Confirms ADCs as frontline platforms, not just late-line salvage therapies Roche Giredestrant Delivers the First Phase III Win for an Oral SERD in Early Breast Cancer Roches oral SERD giredestrant reduced the risk of invasive disease recurrence versus standard endocrine therapy in the Phase III lidERA trial in ER-positive, HER2-negative early breast cancer, marking the first major advance in adjuvant endocrine therapy in decades

J Cell Biol 174:491497 Nieves B, Jones CW, Ward R, Ohta Y, Reverte CG, LaFlamme SE (2010) The NPIY motif in the integrin beta1 tail dictates the requirement for talin-1 in outside-in signaling